ACTRN12617001533381尚未招募4 期
Combination low dose blood pressure lowering treatment for patients with untreated hypertension: Evaluation of short-term safety.
George Medicines0 个研究点目标入组 12 人开始时间: 2017年11月6日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 —（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
尚未招募
4 期
Blood pressure lowering effect of combination therapy of angiotensin receptor blocker (ARB) and Ca antagonist in patients with high risk hypertensioHypertensionJPRN-UMIN000002207Department of Cardiovascular Medicine, Institute of Health Biosciences, The University of Tokushima Graduate School40
已完成
不适用
Medication induced blood pressure reduction; assessment of cerebral perfusion and cognition in hypertensive elderlyhypertensionhigh blood pressure1000796310057166NL-OMON33986niversitair Medisch Centrum Sint Radboud60
已完成
不适用
Blood pressure lowering effect of one compound tablet replacement as two tablets of angiotensin 2 receptor blocker(ARB) and calcium channel blocker(CCB)the hypertensive patient who has taken ARB and CCBJPRN-UMIN000008360Department of Cardiovascular Medicine, Okayama Univesity Graduate School of Medicine, Dentistry and Pharmaceutical Sciences200
招募中
3 期
Treatment of cardiovascular disease with low dose Rivaroxaban in Advanced Chronic Kidney diseaseCTRI/2020/06/025708George Institute for Global Health
尚未招募
不适用
oninvasive cardiac output monitoring to optimise therapy for patients with poorly controlled hypertension: a randomised controlled trialCardiovascular - HypertensionHypertensionACTRN12611001289909The Chinese University of Hong Kong202